Keybank National Association Invitae Corp Transaction History

Keybank National Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$14.7 - $28.67 $109,515 - $213,591	-7,450 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$24.31 - $33.6 $23,313 - $32,222	-959 Reduced 11.4%	7,450 $212,000
Q2 2021 Aug 12, 2021	SELL	$26.09 - $40.4 $26,011 - $40,278	-997 Reduced 10.6%	8,409 $284,000
Q1 2021 May 07, 2021	BUY	$33.06 - $56.93 $48,664 - $83,800	1,472 Added 18.55%	9,406 $359,000
Q4 2020 Feb 09, 2021	BUY	$39.09 - $57.4 $19,545 - $28,700	500 Added 6.73%	7,934 $332,000
Q2 2020 Aug 10, 2020	BUY	$11.71 - $30.29 $87,052 - $225,175	7,434 New	7,434 $225,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.